Medicine Matters oncology

Incidence: Although rare, type I diabetes mellitus is associated with anti-PD-1 and less commonly with anti-PD-L1 agents. Venous glucose levels should be monitored regularly during treatment with anti-PD-1 therapy, given the morbidity associated with DKA.

Onset: Unknown due to rareness